US Patent 11774452 Antibodies against carcinoembryonic antigens
Article
Patent abstract
The invention provides an anti-CEA antibody for use in detecting CEA, treating disorders associated with CEA expression, diagnosing cancers characterized by aberrant CEA expression, and predicting effectiveness of cancer drug therapies.